Developer docs
API playgroundTry for free, no card

Search company profiles

Enfusion

Full company profile

uuid0000c4y

Namestring
Enfusion
Legal namestring
Enfusion, Inc.
Websiteurl
enfusion.com
Company typeenum
Public
Founded yearint
2014
Descriptiontext

Enfusion (now operating as "Enfusion by Clearwater" following its April 2025 acquisition) is a cloud-native SaaS provider of front-office investment management software serving institutional investors, hedge funds, asset managers, and asset owners. Founded in 1998 and headquartered in Chicago, the company built a unified portfolio management, order and execution management, risk analytics, IBOR, and regulatory reporting platform designed to replace fragmented, legacy on-premise investment management workflows with a single integrated environment.

The core technology stack combines proprietary front-office modules — including the Investment Book of Record (IBOR), Portfolio & Order Management, Portfolio Workbench, and Risk & Performance capabilities — with middle- and back-office solutions integrated through Clearwater Analytics following the $1.5 billion acquisition. The combined platform processes over $10 trillion in assets with embedded AI capabilities: 1,000+ autonomous agents automating reconciliation, reporting, accounting, and compliance workflows, supported by Clearwater AI's generative AI layer (C1) and natural-language report generation. Enfusion historically operated a subscription-based SaaS revenue model with annual contracts ranging from approximately $100K to $5M, distributed through direct enterprise field sales and strategic channel partnerships including Northern Trust.

Enfusion generated $201.6 million in 2024 revenue (15.5% year-over-year growth) with ARR of $210.4 million and 103% net dollar retention across 916 institutional clients. The client base spans asset management (OfiInvest, Payden & Rygel, Chandler Asset Management) and insurance (PartnerRe, China Taiping Insurance), with geographic mix of 54% Americas, 27% APAC, and 19% EMEA and dedicated sales offices in New York, Hong Kong, and Singapore. Post-acquisition, Enfusion contributes the front-office layer to Clearwater Analytics' broader product suite, which adds Beacon (cross-asset trading and risk), Compass (investment intelligence), and the broader Clearwater AI platform serving 2,400+ global clients.

Short descriptiontext

Enfusion (now "Enfusion by Clearwater") provides a cloud-native, front-to-back investment management SaaS platform for hedge funds, asset managers, and institutional investors, integrating portfolio management, order execution, IBOR, risk analytics, and regulatory reporting. Acquired by Clearwater Analytics in April 2025.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersChicago, United States
HQ citystring
Chicago
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
investment management SaaS, portfolio management software, order and execution management, hedge fund technology, asset management platform
Industry3 codes
PRIMARYFSAEAAAC
Portfolio Construction & Asset Allocation Advisory
SECONDARYHDAEACAD
iPaaS / Cloud Data Integration
SECONDARYHDAEAIAB
iPaaS (Cloud Integration Platforms)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Application Integration & iPaaS (API Management, ESB)
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Portfolio Management and Investment Advice52394
SIC code3 codes
  • Services-Prepackaged Software7372
  • Services-Computer Integrated Systems Design7373
  • Investment Advice6282
Product category
Investment Management Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Subscription-based SaaS Revenue
TypeSubscription Recurring
Description

Enfusion operates as a SaaS provider generating recurring subscription revenue from its cloud-native investment management platform. The company reported 2024 total revenue of $201.6 million with Annual Recurring Revenue of $210.4 million as of December 2024. Net dollar retention rate stood at 103.0% as of December 2024.

Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details1 tier
1Enterprise pricing typically ranges from $100K-$5M depending on firm size
ModelSubscriptionBilling cadenceAnnual
Notes

Based on buyer's guide analysis for comparable IBOR platforms, pricing scales with asset manager size and scope of implementation

finantrix.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Enfusion provides a cloud-native, unified front-to-back investment management SaaS platform that combines portfolio management, order and execution management, risk analytics, and accounting/reporting for institutional investors, hedge funds, and asset managers. Following its April 2025 acquisition by Clearwater Analytics, the offering now operates as 'Enfusion by Clearwater', integrating front-office capabilities with middle and back-office solutions to streamline the full investment lifecycle.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 103% net dollar retention rate
+2 more records
Product overview1 text field

Enfusion, acquired by Clearwater Analytics in April 2025 for approximately $1.5 billion, operates as a cloud-native investment management SaaS platform now branded as 'Enfusion by Clearwater'. The platform provides a unified front-to-back investment management environment for asset managers, hedge funds, and institutional investors, integrating portfolio management, order execution, and trading capabilities. The broader Clearwater platform processes over $10 trillion in assets and serves 2,400+ global clients. Key products include Enfusion by Clearwater (unified portfolio management and order execution), Beacon by Clearwater (cross-asset trading and risk analytics), and Clearwater Compass (investment intelligence). Supporting modules cover Investment Book of Record, Portfolio & Order Management, Risk & Performance, Accounting & Reporting, Pre- & Post-Trade Compliance, and Regulatory Compliance. Clearwater AI is embedded throughout the platform as an AI-driven workflow layer.

Product and service3 records
1Enfusion by Clearwater
CategoryCore Platform
Description

A front-to-back environment that streamlines portfolio management, trading, and execution for institutional investors and asset managers, enabling seamless transition from investment decisions to action.

2Beacon by Clearwater
CategoryCore Platform
Description

Cross-asset trading and risk management solution providing AI-powered analytics and modeling tools for testing scenarios, evaluating exposures, and understanding portfolio behavior in real time.

3Clearwater Compass
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-07
Description

Northern Trust established a strategic alliance with Enfusion to provide integrated portfolio management, order and execution management, and analytics capabilities to mutual clients. The collaboration enables asset managers, hedge funds, and asset owners to access a unified cloud-native platform combining Northern Trust's asset servicing with Enfusion's SaaS infrastructure. The alliance includes a co-developed certified interface with Equity Data Science and is part of Northern Trust's Whole Office strategy for end-to-end solutions across the investment lifecycle.

2Equity Data Science
Strategic tierSupportingTypeTechnology or IntegrationAnnounced on2025-08-07
Description

Co-developed certified interface with Equity Data Science as part of the Northern Trust-Enfusion strategic alliance, enabling enhanced analytics capabilities for mutual clients.

cwan.com
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-01-13
Description

Clearwater Analytics acquired Enfusion for approximately $1.5 billion (enterprise value), integrating Enfusion's front-office capabilities with Clearwater's middle and back-office solutions to create a unified cloud-native front-to-back platform for institutional investors. The acquisition expanded Clearwater's total addressable market by $1.9 billion and is expected to deliver approximately $20 million in cost synergies.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

BlackRock's Aladdin is the dominant institutional investment management platform combining portfolio management, risk analytics, trading, and operations. It competes head-to-head with Enfusion's unified front-to-back offering at large enterprise asset managers and insurers.

TypeDirect peer
Description

Charles River provides order management, portfolio management, and compliance tools for institutional asset managers and hedge funds. It is one of the closest direct competitors to Enfusion's IBOR and front-office investment management capabilities.

TypeDirect peer
Description

SS&C's Advent platform (Axiom, Geneva, Moxy) provides portfolio management, order management, and accounting for hedge funds and asset managers — directly overlapping Enfusion's core customer base and product functionality.

TypeDirect peer
Description

SimCorp Dimension is an integrated investment management platform serving buy-side institutions with portfolio management, compliance, and analytics — a direct competitor in the institutional asset management segment where Enfusion operates.

5Bloomberg AIM
TypeBroad incumbent
Description

Bloomberg's Asset & Investment Manager (AIM) platform offers order management, portfolio tracking, and analytics to buy-side firms. While part of Bloomberg's broader Terminal ecosystem, it directly competes for the same institutional asset manager and hedge fund clients.

TypeDirect peer
Description

Eze provides front-to-back investment management software including order management, execution, and portfolio analytics for hedge funds and asset managers — closely aligned with Enfusion's core offering and target customer base.

TypeBroad incumbent
Description

Finastra provides capital markets and investment management technology across front, middle, and back office. While broader than Enfusion's niche, it competes for institutional asset manager platform modernization budgets.

TypeEmerging player
Description

Canoe Intelligence uses AI to automate alternative investment document processing and data extraction for institutional investors. It overlaps with Enfusion's alternatives-focused workflows and Clearwater's broader alternative asset data strategy.

TypeOthers
Description

Northern Trust's Whole Office strategy combines its asset servicing capabilities with partner platforms (including Enfusion) to deliver integrated front-to-back investment solutions. As a strategic partner and competitor-adjacent platform, it shapes Enfusion's go-to-market motion.

TypeEmerging player
Description

Orion provides portfolio accounting, performance reporting, and trading technology to wealth managers and asset managers. While more wealth-management-focused, it competes for adjacent institutional platform spend and modernization budgets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Enfusion

Investment Management Softwareenfusion.com

Enfusion (now "Enfusion by Clearwater") provides a cloud-native, front-to-back investment management SaaS platform for hedge funds, asset managers, and institutional investors, integrating portfolio management, order execution, IBOR, risk analytics, and regulatory reporting. Acquired by Clearwater Analytics in April 2025.

What Enfusion does

Enfusion (now operating as "Enfusion by Clearwater" following its April 2025 acquisition) is a cloud-native SaaS provider of front-office investment management software serving institutional investors, hedge funds, asset managers, and asset owners. Founded in 1998 and headquartered in Chicago, the company built a unified portfolio management, order and execution management, risk analytics, IBOR, and regulatory reporting platform designed to replace fragmented, legacy on-premise investment management workflows with a single integrated environment.

The core technology stack combines proprietary front-office modules — including the Investment Book of Record (IBOR), Portfolio & Order Management, Portfolio Workbench, and Risk & Performance capabilities — with middle- and back-office solutions integrated through Clearwater Analytics following the $1.5 billion acquisition. The combined platform processes over $10 trillion in assets with embedded AI capabilities: 1,000+ autonomous agents automating reconciliation, reporting, accounting, and compliance workflows, supported by Clearwater AI's generative AI layer (C1) and natural-language report generation. Enfusion historically operated a subscription-based SaaS revenue model with annual contracts ranging from approximately $100K to $5M, distributed through direct enterprise field sales and strategic channel partnerships including Northern Trust.

Enfusion generated $201.6 million in 2024 revenue (15.5% year-over-year growth) with ARR of $210.4 million and 103% net dollar retention across 916 institutional clients. The client base spans asset management (OfiInvest, Payden & Rygel, Chandler Asset Management) and insurance (PartnerRe, China Taiping Insurance), with geographic mix of 54% Americas, 27% APAC, and 19% EMEA and dedicated sales offices in New York, Hong Kong, and Singapore. Post-acquisition, Enfusion contributes the front-office layer to Clearwater Analytics' broader product suite, which adds Beacon (cross-asset trading and risk), Compass (investment intelligence), and the broader Clearwater AI platform serving 2,400+ global clients.

Enfusion firmographics

Firmographics
Name
Enfusion
Legal name
Enfusion, Inc.
Website
https://enfusion.com
Company type
Public
Founded year
2014
Operating status
Acquired
Headcount range
5,001–10,000 employees
Short description
Enfusion (now "Enfusion by Clearwater") provides a cloud-native, front-to-back investment management SaaS platform for hedge funds, asset managers, and institutional investors, integrating portfolio management, order execution, IBOR, risk analytics, and regulatory reporting. Acquired by Clearwater Analytics in April 2025.
Ownership category
akta.pro rank

Enfusion industry classification

Industry
Product category
Investment Management Software
NAICS
Portfolio Management and Investment Advice (523940), Portfolio Management and Investment Advice (52394)
SIC
Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373), Investment Advice (6282)
akta.pro industry
PRIMARYFSAEAAAC
Portfolio Construction & Asset Allocation Advisory
SECONDARYHDAEACAD
iPaaS / Cloud Data Integration
SECONDARYHDAEAIAB
iPaaS (Cloud Integration Platforms)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Application Integration & iPaaS (API Management, ESB)

Keywords

  • Investment management SaaS
  • Portfolio management software
  • Order and execution management
  • Hedge fund technology
  • Asset management platform

Where Enfusion is headquartered

Location

Headquarters

HQ city
Chicago
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Enfusion business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Subscription-based SaaS Revenue: Enfusion operates as a SaaS provider generating recurring subscription revenue from its cloud-native investment management platform. The company reported 2024 total revenue of $201.6 million with Annual Recurring Revenue of $210.4 million as of December 2024. Net dollar retention rate stood at 103.0% as of December 2024.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise pricing typically ranges from $100K-$5M depending on firm size

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Enfusion product offering

Product offering

Core offering

Enfusion provides a cloud-native, unified front-to-back investment management SaaS platform that combines portfolio management, order and execution management, risk analytics, and accounting/reporting for institutional investors, hedge funds, and asset managers. Following its April 2025 acquisition by Clearwater Analytics, the offering now operates as 'Enfusion by Clearwater', integrating front-office capabilities with middle and back-office solutions to streamline the full investment lifecycle.

Product overview

Enfusion, acquired by Clearwater Analytics in April 2025 for approximately $1.5 billion, operates as a cloud-native investment management SaaS platform now branded as 'Enfusion by Clearwater'. The platform provides a unified front-to-back investment management environment for asset managers, hedge funds, and institutional investors, integrating portfolio management, order execution, and trading capabilities. The broader Clearwater platform processes over $10 trillion in assets and serves 2,400+ global clients. Key products include Enfusion by Clearwater (unified portfolio management and order execution), Beacon by Clearwater (cross-asset trading and risk analytics), and Clearwater Compass (investment intelligence). Supporting modules cover Investment Book of Record, Portfolio & Order Management, Risk & Performance, Accounting & Reporting, Pre- & Post-Trade Compliance, and Regulatory Compliance. Clearwater AI is embedded throughout the platform as an AI-driven workflow layer.

Differentiator

Problem solved

Functional benefit

Products and services

  • Enfusion by Clearwater A front-to-back environment that streamlines portfolio management, trading, and execution for institutional investors and asset managers, enabling seamless transition from investment decisions to action.
  • Beacon by Clearwater Cross-asset trading and risk management solution providing AI-powered analytics and modeling tools for testing scenarios, evaluating exposures, and understanding portfolio behavior in real time.
  • Clearwater Compass

Quantifiable outcome

  • 103% net dollar retention rate
  • +2 more outcomes

Companies that use Enfusion

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Enfusion technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature3 records

Enfusion partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core, supporting and flagship.

  • Northern TrustcoreStrategic or Co-development Partner · 7 August 2025Northern Trust established a strategic alliance with Enfusion to provide integrated portfolio management, order and execution management, and analytics capabilities to mutual clients. The collaboration enables asset managers, hedge funds, and asset owners to access a unified cloud-native platform combining Northern Trust's asset servicing with Enfusion's SaaS infrastructure. The alliance includes a co-developed certified interface with Equity Data Science and is part of Northern Trust's Whole Office strategy for end-to-end solutions across the investment lifecycle.
  • Equity Data SciencesupportingTechnology or Integration · 7 August 2025Co-developed certified interface with Equity Data Science as part of the Northern Trust-Enfusion strategic alliance, enabling enhanced analytics capabilities for mutual clients.
  • Clearwater AnalyticsflagshipStrategic or Co-development Partner · 13 January 2025Clearwater Analytics acquired Enfusion for approximately $1.5 billion (enterprise value), integrating Enfusion's front-office capabilities with Clearwater's middle and back-office solutions to create a unified cloud-native front-to-back platform for institutional investors. The acquisition expanded Clearwater's total addressable market by $1.9 billion and is expected to deliver approximately $20 million in cost synergies.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Enfusion competitors and assessment

Company assessment

Broad incumbents

  • BlackRock Aladdin: BlackRock's Aladdin is the dominant institutional investment management platform combining portfolio management, risk analytics, trading, and operations. It competes head-to-head with Enfusion's unified front-to-back offering at large enterprise asset managers and insurers.
  • Bloomberg AIM: Bloomberg's Asset & Investment Manager (AIM) platform offers order management, portfolio tracking, and analytics to buy-side firms. While part of Bloomberg's broader Terminal ecosystem, it directly competes for the same institutional asset manager and hedge fund clients.
  • Finastra: Finastra provides capital markets and investment management technology across front, middle, and back office. While broader than Enfusion's niche, it competes for institutional asset manager platform modernization budgets.

Direct peers

  • State Street Charles River Development: Charles River provides order management, portfolio management, and compliance tools for institutional asset managers and hedge funds. It is one of the closest direct competitors to Enfusion's IBOR and front-office investment management capabilities.
  • SS&C Advent: SS&C's Advent platform (Axiom, Geneva, Moxy) provides portfolio management, order management, and accounting for hedge funds and asset managers — directly overlapping Enfusion's core customer base and product functionality.
  • SimCorp: SimCorp Dimension is an integrated investment management platform serving buy-side institutions with portfolio management, compliance, and analytics — a direct competitor in the institutional asset management segment where Enfusion operates.
  • Eze Software (SS&C Eze): Eze provides front-to-back investment management software including order management, execution, and portfolio analytics for hedge funds and asset managers — closely aligned with Enfusion's core offering and target customer base.

Emerging players

  • Canoe Intelligence: Canoe Intelligence uses AI to automate alternative investment document processing and data extraction for institutional investors. It overlaps with Enfusion's alternatives-focused workflows and Clearwater's broader alternative asset data strategy.
  • Orion Advisor Solutions: Orion provides portfolio accounting, performance reporting, and trading technology to wealth managers and asset managers. While more wealth-management-focused, it competes for adjacent institutional platform spend and modernization budgets.

Others

  • Northern Trust Whole Office: Northern Trust's Whole Office strategy combines its asset servicing capabilities with partner platforms (including Enfusion) to deliver integrated front-to-back investment solutions. As a strategic partner and competitor-adjacent platform, it shapes Enfusion's go-to-market motion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Enfusion social profiles

Digital presence

Enfusion financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Enfusion leadership team

Management profile

Number of profiles

Profiles9 records

Enfusion funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Enfusion M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Enfusion

What does Enfusion do?

Enfusion provides a cloud-native, unified front-to-back investment management SaaS platform that combines portfolio management, order and execution management, risk analytics, and accounting/reporting for institutional investors, hedge funds, and asset managers. Following its April 2025 acquisition by Clearwater Analytics, the offering now operates as 'Enfusion by Clearwater', integrating front-office capabilities with middle and back-office solutions to streamline the full investment lifecycle.

Is Enfusion a public or private company?

Enfusion is a public company. It is classified as corporate owned and is currently acquired.

When was Enfusion founded?

Enfusion was founded in 2014. It employs 5,001 to 10,000 people.

Where is Enfusion based?

Enfusion is headquartered in Chicago, United States, in the North America region.

How does Enfusion make money?

One revenue line is on record: subscription-based SaaS Revenue.

Who are Enfusion's main competitors?

Broad incumbents on record are BlackRock Aladdin, Bloomberg AIM and Finastra. Direct peers are State Street Charles River Development, SS&C Advent, SimCorp and Eze Software (SS&C Eze). Emerging players are Canoe Intelligence and Orion Advisor Solutions. Northern Trust Whole Office is listed as an others.

Does Enfusion have an API?

No public API is recorded for Enfusion.

What industry is Enfusion in?

Enfusion's product category is Investment Management Software. Its primary akta.pro industry code is FSAEAAAC, Portfolio Construction & Asset Allocation Advisory, with a secondary code of HDAEACAD, iPaaS / Cloud Data Integration. Its NAICS code is 523940 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Simply Wall St3 RegTech Stocks Helping Firms Keep Up With New Compliance RulesSimply Wall St published an article profiling three RegTech stocks—Intapp, EngageSmart, and Enfusion—as potential beneficiaries of tightening regulatory oversight and evolving global trade rules. The article discusses each company's operations, revenue, and market cap: Intapp (US$560.3m revenue, US$1.7b market cap), EngageSmart (US$364.5m revenue, US$3.9b market cap), and Enfusion (US$201.6m revenue, US$1.4b market cap). The piece balances positive positioning around regulatory alignment with investment considerations including valuation concerns, profitability challenges, and higher-risk capital structures for each profiled company.Simply Wall StImport Export Logistics Stocks One Discount One Momentum One QuestionSimply Wall St published a stock analysis article highlighting three companies positioned around import/export logistics and customs compliance themes amid new tariff rules. The coverage includes Spartan Resources (an Australian gold explorer with trade compliance operations trading at a significant discount), Shadowfax Technologies (an Indian third-party logistics company with strong earnings momentum but a high valuation), and Enfusion (a U.S.-based financial software provider serving investment managers with cross-border trading needs). The article serves as promotional content for Simply Wall St's stock screening tools, presenting balanced analysis that acknowledges growth potential alongside execution risks and valuation concerns for each company.EnfusionEnfusion Investment Management SolutionEnfusion promotes its investment management platform designed to replace fragmented workflows with a unified front-to-back system for hedge funds and asset managers. The solution provides real-time reporting, integrated execution with pre-trade compliance checks, and a single source of truth for positions and P&L across 30 countries.CwanClearwater Analytics to Acquire Enfusion for $1.5BClearwater Analytics announced its acquisition of Enfusion for approximately $1.5 billion, with Enfusion shareholders set to receive $11.25 per share in an approximately equal mix of cash and stock, plus an additional $30 million to terminate Enfusion's tax receivable agreement. The deal represents a 13% premium over Enfusion's January 10, 2025 closing price and is expected to close in Q2 2025, subject to Enfusion shareholder approval and regulatory clearance. The combined entity aims to create a unified cloud-native front-to-back platform for investment managers, expand into the hedge fund industry, and grow internationally, with Clearwater expecting approximately $20 million in cost savings and significant margin expansion.The Motley FoolClearwater (CWAN) Q3 2025 Earnings Call TranscriptClearwater Analytics reported Q3 2025 non-GAAP revenue of $205.1 million, up 77% year-over-year, and adjusted EBITDA of $70.7 million with a 34.5% margin, exceeding guidance by over $5 million in the first full quarter following the integration of Enfusion, Beacon, and Bistro. Annualized recurring revenue reached a record $807.5 million, up 77% year-over-year, while gross revenue retention held steady at 98% and net revenue retention was 108%, declining slightly from 110% in Q2. The company guided for Q4 2025 revenue of $216-217 million (71-72% YoY growth) and full-year 2025 revenue of $730-731 million (approximately 62% YoY growth).FinantrixBuyer’s Guide: Investment Book of Record (IBOR) Platforms for Asset ManagersThis buyer's guide examines the Investment Book of Record (IBOR) platform market for asset managers, noting that cloud-native solutions now process over $45 trillion in assets under management globally, with 73% of asset managers planning IBOR upgrades by 2027. The guide analyzes major vendors including SimCorp Dimension, Charles River Development, Eze Software, Advent Software, Enfusion, Broadridge, and Allvue Systems, providing pricing ranges from $100K-$5M depending on firm size, implementation timelines of 12-18 months, and a build-versus-buy analysis recommending commercial platforms for most asset managers given the $15-25M cost of in-house development.AD HOC NEWSEnfusion Inc Stock Climbs on Platform Expansion: What European Investors Should KnowEnfusion Inc, a cloud-native investment management software platform, is experiencing growing adoption among European asset managers as regulatory pressure (MiFID II, EMIR, ESG reporting) and margin compression drive demand for modernized technology infrastructure. The company serves buy-side institutions managing trillions in assets through a recurring SaaS model generating 70%+ gross margins, with German and Swiss asset managers specifically citing multi-currency settlement, derivatives risk, and ESG integration capabilities as key decision drivers. For European and DACH investors, Enfusion represents exposure to the secular trend of consolidation of fragmented legacy technology onto cloud-native platforms, with European adoption particularly among German, Swiss, and Nordic asset managers identified as a meaningful growth driver.Seeking AlphaClearwater: How Its Agentic AI Could Be The Future Nervous System Of $10 Trillion AssetsClearwater Analytics (CWAN) signed an $8.4 billion acquisition agreement with private equity consortium Permira and Warburg Pincus at $24.5 per share, as the company transitions from accounting software provider to an AI-driven asset management platform with over 900 autonomous AI agents. The company's Q4 revenues surged 72% YoY to $217.5 million with 98% gross revenue retention, driven by strategic acquisitions including Enfusion, Beacon, and Blackstone's Bistro that expanded its capabilities across the investment cycle. Key risks include deal completion uncertainty, complex integration of acquired entities, and potential AI errors in a highly regulated environment.Seeking AlphaClearwater: How Its Agentic AI Could Be The Future Nervous System Of $10 Trillion AssetsClearwater Analytics (CWAN) signed a final acquisition agreement with private equity firms Permira and Warburg Pincus in an $8.4 billion deal ($24.5 per share), representing a significant premium as the company transitions into an AI-driven platform serving the asset management industry. The company's Agentic AI platform, featuring 900+ autonomous agents, drives 98% gross revenue retention over 27 of 28 quarters, 72% year-over-year revenue growth in Q4, and $841M in annual recurring revenue, while recent acquisitions of Enfusion, Beacon, and Bistro have expanded capabilities across the investment cycle. Key risks include acquisition completion uncertainty, complex integration challenges of acquired entities, and potential AI errors in a highly regulated environment.